Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 39, Issue 1, Pages 179-186
Publisher
SAGE Publications
Online
2013-02-28
DOI
10.1177/147323001103900119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Polymorphisms of MTHFR and Aberrant Promoter Hypermethylation of the RASSF1A Gene in Bladder Cancer Risk in a Chinese Population
- (2013) DW Cai et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Methylation in p14ARF is Frequently Observed in Colorectal Cancer with Low-level Microsatellite Instability
- (2013) K Kominami et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Bladder Cancer in 2010: How Far have We Come?
- (2010) B. L. Jacobs et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
- (2010) N. Shivapurkar et al. CURRENT MOLECULAR MEDICINE
- Bladder cancer
- (2010) Todd M Morgan et al. CURRENT OPINION IN ONCOLOGY
- DNA methylation as a universal biomarker
- (2010) Victor V Levenson EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT)
- (2009) Li-Mei Chen et al. BMC CANCER
- Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
- (2009) Bas W.G. van Rhijn et al. EUROPEAN UROLOGY
- DNA methylation and cancer diagnosis: new methods and applications
- (2009) Pierre Dehan et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Epigenetic biomarkers in urothelial bladder cancer
- (2009) Wun-Jae Kim et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- H-Cadherin expression reduces invasion of malignant melanoma
- (2009) Silke Kuphal et al. Pigment Cell & Melanoma Research
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
- Epigenetics in bladder cancer
- (2008) Hideki Enokida et al. International Journal of Clinical Oncology
- Molecular markers for detection, surveillance and prognostication of bladder cancer
- (2008) Olaf PJ Vrooman et al. INTERNATIONAL JOURNAL OF UROLOGY
- Epigenetic markers as promising prognosticators for bladder cancer
- (2008) Young Kyoon Kim et al. INTERNATIONAL JOURNAL OF UROLOGY
- DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
- (2008) Malcolm V. Brock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bladder cancer: Clinical and pathological profile
- (2008) Antonio Lopez-Beltran SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
- (2008) Christian Bolenz et al. Nature clinical practice. Urology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now